You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Optimal Management of Nontuberculous Mycobacterial Lung Disease: A Clinical Olympics Proceedings

  • Authors: Pamela J. McShane, MD; Charles L. Daley, MD; Kevin L. Winthrop, MD, MPH
  • CME Released: 12/6/2022
  • Valid for credit through: 12/5/2023, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

Infectious disease specialists, pulmonologists, geriatricians, primary care, and other clinicians who manage patients with nontuberculous mycobacterial lung disease (NTM-LD).


The goal of this activity is to raise awareness of NTM-LD to ensure a timely accurate diagnosis and personalized treatment in newly diagnosed and refractory patients.


Upon completion of this activity, participants should be better able to:

  1. Identify patients who are at risk for developing NTM-LD
  2. Diagnose patients with NTM-LD according to current criteria and established testing methods
  3. Develop personalized treatment regimens for patients with NTM-LD


RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy.


  • Pamela J. McShane, MD

    Associate Professor of Medicine
    Department of Medicine
    Division of Pulmonary and Critical Care
    The University of Texas at Tyler
    Tyler, Texas


    Pamela J. McShane, MD, has the following relevant financial relationships:
    Consultant for: Boehringer Ingelheim
    Speaker or member of speakers bureau for: Insmed
    Contracted researcher for: AN2; AstraZeneca; Boehringer Ingelheim; Electromed; Insmed; Paratek


  • Charles L. Daley, MD

    Chief, Division of Mycobacterial and Respiratory Infections
    Professor of Medicine
    National Jewish Health
    Denver, Colorado


    Charles L. Daley, MD, has the following relevant financial relationships:
    Advisor for: AN2; Insmed; Mannkind; Matinas; Paratek; Spero
    Consultant for: Genentech; LegoChem Biosciences; Pfizer
    Data Monitoring Committee for: Eli Lilly; Otsuka
    Grant/Research Support for: AN2; Beyond Air; bioMérieux; Bugworks; Insmed; Paratek

  • Kevin L. Winthrop, MD, MPH

    Professor of Infectious Diseases, Ophthalmology
    Professor of Public Health and Preventive Medicine (joint appointment)
    Oregon Health and Science University
    Portland, Oregon


    Kevin L. Winthrop, MD, MPH, has the following relevant financial relationships:
    Consultant for: AN2; Insmed; Paratek; RedHill Biopharma; Spero Therapeutics
    Research funding from: AN2; Insmed; Paratek; RedHill Biopharma

All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies.

Planners and Managers

RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Accreditation Statements

Interprofessional Continuing Education

In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • RMEI Medical Education, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Optimal Management of Nontuberculous Mycobacterial Lung Disease: A Clinical Olympics Proceedings

Authors: Pamela J. McShane, MD; Charles L. Daley, MD; Kevin L. Winthrop, MD, MPHFaculty and Disclosures

CME Released: 12/6/2022

Valid for credit through: 12/5/2023, 11:59 PM EST


Assessment Survey

Before you begin, please take this brief survey.

  • Print